Sharon Odell
Internal Medicine · Marietta, GANPI 1003867300
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,047 and has fallen 57.9% since, to $440 in 2022.
Across 196 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$605
- AstraZeneca$359
- AbbVie$338
- Novo Nordisk$210
- Takeda Pharmaceuticals U.S.A., Inc.$186
- Astellas Pharma US Inc$182
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,177100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 37 | $605 |
| AstraZeneca | 24 | $359 |
| AbbVie(2 entities) | 21 | $338 |
| Novo Nordisk | 12 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $186 |
| Astellas Pharma US Inc | 9 | $182 |
| Amarin Pharma, Inc. | 11 | $162 |
| Lilly USA, LLC | 10 | $151 |
| Merck | 10 | $144 |
| Pfizer | 8 | $125 |
| Boehringer Ingelheim | 6 | $123 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Johnson & Johnson | 6 | $93 |
| GSK | 4 | $79 |
| Bayer | 3 | $63 |
| Sunovion Pharmaceuticals Inc. | 3 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Aytu Biopharma, Inc. | 2 | $34 |
| Eisai Inc. | 2 | $33 |
| Radius Health, Inc. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Abbott | 1 | $15 |
| Medtronic | 1 | $15 |
| Gilead | 1 | $12 |
How this compares
$3,177 in reported general payments places this provider in the 80th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Marietta
- Ebon BourneMarietta$242K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.